Previous close | 7.50 |
Open | 7.50 |
Bid | 4.40 |
Ask | 4.70 |
Strike | 135.00 |
Expiry date | 2024-06-21 |
Day's range | 7.50 - 7.50 |
Contract range | N/A |
Volume | |
Open interest | 183 |
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, today announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases.
A week ago, Quest Diagnostics Incorporated ( NYSE:DGX ) came out with a strong set of first-quarter numbers that could...